For the quarter ending 2025-09-30, SRPT has $3,493,437K in assets. $2,173,317K in debts. $613,077K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 613,077 | 510,598 | ||
| Short-term investments | 237,916 | 289,541 | ||
| Accounts receivable, net | 395,739 | 527,295 | ||
| Inventory | 1,077,166 | 994,036 | ||
| Manufacturing-related deposits and prepaids | 206,062 | 207,921 | ||
| Other current assets | 192,349 | 127,594 | ||
| Total current assets | 2,722,309 | 2,656,985 | ||
| Property and equipment, net | 358,936 | 371,857 | ||
| Right of use assets | 139,167 | 143,041 | ||
| Non-current inventory | 198,601 | 194,668 | ||
| Non-current investments | 1,040 | 34,604 | ||
| Strategic investments | - | 195,522 | ||
| Other non-current assets | 73,384 | 83,137 | ||
| Total assets | 3,493,437 | 3,679,814 | ||
| Accounts payable | 94,015 | 136,702 | ||
| Accrued expenses | 295,793 | 377,399 | ||
| Deferred revenue, current portion | 485,449 | 395,431 | ||
| Contingent consideration, current portion | 36,000 | - | ||
| Other current liabilities | 10,168 | 10,416 | ||
| Total current liabilities | 921,425 | 919,948 | ||
| Long-term debt | 1,035,146 | 1,139,458 | ||
| Lease liabilities, net of current portion | 215,042 | 214,419 | ||
| Deferred revenue, net of current portion | 0 | 0 | ||
| Contingent consideration, net of current portion | 300 | - | ||
| Contingent consideration | - | 47,400 | ||
| Other non-current liabilities | 1,404 | 1,204 | ||
| Total liabilities | 2,173,317 | 2,322,429 | ||
| Common stock, 0.0001 par value, 198,000,000 shares authorized 105,418,987 and 104,768,111 issued and outstanding, respectively, at september 30, 2025, and 96,900,496 issued and outstanding at december 31, 2024 | 11 | 10 | ||
| Treasury stock, at cost, 650,876 and 0 shares at september 30, 2025 and december 31, 2024, respectively | 25,263 | 25,263 | ||
| Additional paid-in capital | 5,986,689 | 5,844,279 | ||
| Accumulated other comprehensive loss, net of tax | 220 | -51 | ||
| Accumulated deficit | -4,641,537 | -4,461,590 | ||
| Total stockholders equity | 1,320,120 | 1,357,385 | ||
| Total liabilities and stockholders equity | 3,493,437 | 3,679,814 | ||
Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics, Inc. (SRPT)